Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance

Patsouris, David, Müller, Michael ORCID: https://orcid.org/0000-0002-5930-9905 and Kersten, Sander (2004) Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance. Current Opinion in Investigational Drugs, 5 (10). pp. 1045-50. ISSN 1472-4472

Full text not available from this repository. (Request a copy)

Abstract

Peroxisome proliferator activated receptors (PPARs) are a group of ligand-activated transcription factors that play critical roles in the regulation of energy metabolism. Synthetic agonists for these receptors are used in the treatment of type 2 diabetes mellitus and dyslipidemia. Current data linking PPAR and/or PPAR ligands with the treatment of insulin resistance will be critically reviewed, with the focus on important advances over the past year.

Item Type:	Article
Uncontrolled Keywords:	animals,diabetes mellitus, type 2,humans,hypoglycemic agents,insulin resistance,ligands,peroxisome proliferator-activated receptors,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User:	Pure Connector
Date Deposited:	07 Jul 2014 12:04
Last Modified:	24 Oct 2022 06:08
URI:	https://ueaeprints.uea.ac.uk/id/eprint/47746
DOI:

Actions (login required)

View Item